| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/CLINIDS/21.5.1234 |
| P698 | PubMed publication ID | 8589148 |
| P2093 | author name string | Moreno F | |
| Jorgensen JH | |||
| Melcher GP | |||
| Patterson JE | |||
| Crisp C | |||
| Grota P | |||
| Magnon K | |||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | epidemiology | Q133805 |
| Enterococcus faecium | Q140010 | ||
| vancomycin | Q424027 | ||
| urban ecology | Q1430301 | ||
| P304 | page(s) | 1234-1237 | |
| P577 | publication date | 1995-11-01 | |
| P1433 | published in | Clinical Infectious Diseases | Q5133764 |
| P1476 | title | Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. | |
| P478 | volume | 21 |
| Q30307268 | A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control |
| Q54058047 | A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia. |
| Q46914675 | A population-based investigation of invasive vancomycin-resistant Enterococcus infection in metropolitan Atlanta, Georgia, and predictors of mortality |
| Q43648276 | Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit |
| Q37441557 | Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. |
| Q46481043 | Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococci |
| Q35023275 | Antibiotic-induced enterococcal expansion in the mouse intestine occurs throughout the small bowel and correlates poorly with suppression of competing flora |
| Q39557285 | Antimicrobial resistance in enterococci isolated from Turkey flocks fed virginiamycin. |
| Q34974995 | Application of molecular techniques to the study of hospital infection |
| Q43681137 | Clinical and molecular characterization of vancomycin-resistant Enterococcus faecium strains during establishment of endemicity |
| Q40012977 | Clonal dissemination and colony morphotype variation of vancomycin-resistant Enterococcus faecium isolates in metropolitan Detroit, Michigan |
| Q74532186 | Clonal dissemination of vancomycin-resistant Enterococci and comparison of susceptibility testing methods |
| Q57661227 | Control of Transmission of Vancomycin-Resistant Enterococcus faecium in a Long-Term–Care Facility |
| Q41695170 | Diversity among multidrug-resistant enterococci |
| Q35207941 | Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients |
| Q44159621 | Effect of gastrointestinal bleeding and oral medications on acquisition of vancomycin-resistant Enterococcus faecium in hospitalized patients |
| Q34645156 | Effects of antibiotics on nosocomial epidemiology of vancomycin-resistant enterococci |
| Q36544681 | Emergence and dissemination of a highly vancomycin-resistant vanA strain of Enterococcus faecium at a large teaching hospital |
| Q28362182 | Emergence of vancomycin-resistant enterococci |
| Q39686975 | Emergence of vancomycin-resistant enterococci in San Francisco Bay area hospitals during 1994 to 1998. |
| Q33403883 | Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice |
| Q39552917 | Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium at separate hospitals in Boston, Massachusetts |
| Q33965678 | Epidemiology of glycopeptide-resistant enterococci colonizing high-risk patients in hospitals in Johannesburg, Republic of South Africa |
| Q44930325 | Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile |
| Q30452864 | Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis |
| Q39473837 | Geographic distribution of a large mobile element that transfers ampicillin and vancomycin resistance between Enterococcus faecium strains |
| Q39474863 | Identification and characterization of vanB2 glycopeptide resistance elements in enterococci isolated in Scotland |
| Q39458048 | Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. |
| Q39954529 | Local genetic patterns within a vancomycin-resistant Enterococcus faecalis clone isolated in three hospitals in Portugal |
| Q35891501 | Low prevalence of gastrointestinal colonization with antimicrobial-resistant bacteria in high risk units in a Canadian tertiary care centre |
| Q35575216 | Methods used for the isolation, enumeration, characterisation and identification of Enterococcus spp. 2. Pheno- and genotypic criteria. |
| Q33688030 | Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period |
| Q36546431 | Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey |
| Q33964133 | Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period. |
| Q40573547 | Multilevel population genetic analysis of vanA and vanB Enterococcus faecium causing nosocomial outbreaks in 27 countries (1986-2012). |
| Q54131312 | Multiresistant bacteria as a hospital epidemic problem. |
| Q33960971 | Occurrence of a multidrug-resistant Pseudomonas aeruginosa clone in different hospitals in Rio de Janeiro, Brazil |
| Q35622545 | Population biology of Gram-positive pathogens: high-risk clones for dissemination of antibiotic resistance |
| Q43844989 | Risk factors for colonization with vancomycin-resistant enterococci in a Melbourne hospital |
| Q35166035 | Risk factors for new detection of vancomycin-resistant enterococci in acute-care hospitals that employ strict infection control procedures |
| Q24798006 | Rotating antibiotics in the intensive care unit: feasible, apparently beneficial, but questions remain |
| Q33827956 | The microbial genetics of antibiotic cycling |
| Q33655896 | Vancomycin-resistant Enterococcus in liver transplant patients |
| Q34189603 | Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients. |
| Q73498762 | Vancomycin-resistant enterococci |
| Q33975592 | Vancomycin-resistant enterococci |
| Q36170170 | Vancomycin-resistant enterococci in Canada revisited |
| Q41676884 | Vancomycin-resistant enterococci. Mechanism and clinical relevance |
| Q34521387 | Vancomycin-resistant enterococci: why are they here, and where do they come from? |
| Q41502746 | Vancomycin-resistant enterococcus. Detection, epidemiology, and control measures |
| Q39785102 | Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study |
| Q33964155 | vanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality |
Search more.